Sionna Therapeutics, Inc.
SION · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $16 | $15 | $14 | $14 |
| G&A Expenses | $0 | $7 | $6 | $4 |
| SG&A Expenses | $8 | $7 | $6 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $24 | $22 | $20 | $18 |
| Operating Income | -$24 | -$22 | -$20 | -$18 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $4 | $4 | $3 | $2 |
| Pre-Tax Income | -$20 | -$18 | -$16 | -$16 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$20 | -$18 | -$16 | -$16 |
| % Margin | – | – | – | – |
| EPS | -0.456 | -0.41 | -0.374 | -0.359 |
| % Growth | -11.2% | -9.7% | -4.1% | – |
| EPS Diluted | -0.456 | -0.41 | -0.374 | -0.359 |
| Weighted Avg Shares Out | 44 | 44 | 44 | 44 |
| Weighted Avg Shares Out Dil | 44 | 44 | 44 | 44 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $4 | $3 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$20 | -$18 | -$19 | -$18 |
| % Margin | – | – | – | – |